Dear all Please find below the ICB process for disputing your IIF achievement for 22-23. Kind regards Lesley
Lesley Williams Assistant Director Primary Care Strategy Londonwide LMCs and Londonwide Enterprise Ltd Phone: 020 7387 2034/7418 Ext: *221 Fax: 020 7383 7442 Email [email protected]; Website: www.lmc.org.uk; ---------------------------- 🌲 Think of the environment. Do you really need to print this email? This email and any files transmitted with it are confidential and intended solely for the use of the individual or entity to whom they are addressed. If you have received this email in error please accept our apologies and notify the sender. The registered and office address for Londonwide Local Medical Committees Limited is: Tavistock House South, Tavistock Square, London WC1H 9LG. Registered in England No: 6391298. Londonwide Enterprise Limited is a wholly owned subsidiary of Londonwide Local Medical Committees Limited. Londonwide Enterprise Limited is registered at: Tavistock House South, Tavistock Square, London WC1H 9LG. Registered in England No. 6990874. Londonwide Enterprise Limited is registered as a Company Limited by Shares. VAT no: 130 1454 66. Londonwide Local Medical Committees Limited and Londonwide Enterprise Limited do not provide legal or financial advice and thereby excludes all liability howsoever arising in circumstances where any individual, person or entity has suffered any loss or damage arising from the use of information provided by Londonwide Local Medical Committees Limited and Londonwide Enterprise Limited in circumstances where professional legal or financial advice ought reasonably to have been obtained. Londonwide Local Medical Committees Limited and Londonwide Enterprise Limited provide guidance and support to GPs and practice teams in the Londonwide area. Additionally Londonwide Local Medical Committees Limited provides representation to GPs and practice teams in the Londonwide area. Londonwide Local Medical Committees Limited and Londonwide Enterprise Limited strongly advises individuals or practices to obtain independent legal or financial advice. From: KEANE, Alan (NHS NORTH WEST LONDON ICB - W2U3Z) <[email protected]<mailto:[email protected]>> Sent: Monday, November 13, 2023 12:55 PM To: Vicky Ferlia <[email protected]<mailto:[email protected]>>; Lesley Williams <[email protected]<mailto:[email protected]>>; Jamie Wright <[email protected]<mailto:[email protected]>> Cc: SEHGAL, Javina (NHS NORTH WEST LONDON ICB - W2U3Z) <[email protected]<mailto:[email protected]>>; SANDS, Julie (NHS NORTH WEST LONDON ICB - W2U3Z) <[email protected]<mailto:[email protected]>> Subject: RE: IIF Dispute Process Many thanks Vicky. The e-mail has been amended in accordance with your comments and I will circulate to CD’s this afternoon. Many thanks Alan ………………………….. Dear colleagues Following our emails earlier this year, we are writing to you to further clarify the process in relation to the CQRS calculation and the dispute process in place for the PCN Network Contract DES Investment and Impact Fund (IIF) achievement for financial year 2022-23. Calculation The Network Contract DES - IIF is a point-based scheme with a value of each point, that is calculated by dividing the numerator by the denominator, and adjusted subject to a PCN list size and prevalence factor. There is a maximum of 989 points available to participating PCNs for the financial year 2022/23 scheme. Each point value is worth £200. The PCN achievement is calculated based on the achievement of each indicator, that has been extracted and aggregated, multiplied by the value of an IIF point, multiplied by a list size adjustment and, in the case of Quantitative indicators, then multiplied by a prevalence adjustment. For PCNs that have signed up to participate in the IIF for financial year 2022/23, they are entitled a Total Achievement Payment which is the sum of achievement payments for each indicator. Further details are available on NHS England website: https://www.england.nhs.uk/wp-content/uploads/2022/03/B1963-iii-Network-contract-IIF-Implementation-Guidance-September-2022.pdf Annex A of the guidance provides an overview of the prevalence adjustment and list size adjustment. Annex C of the guidance provides further details about the calculation of these adjustments. Disputing the extracted data If your PCN believes that there are discrepancies between the PCN data and the CQRS extraction, please refer to the following steps prior to formally requesting changes to your PCN achievement. • Your PCN nominated CQRS users, of which there should be two, should review your PCN data, numerators, denominators and register for each indicator on CQRS; • The CQRS figures should be compared against the PCN data achievement on your nominated clinical reporting software dashboard. For PCN’s who do not have access to clinical reporting software, please contact your clinical system supplier to obtain access to your PCN data; • If there are discrepancies, please send a screenshot of the particular indicators showing the numerators and denominators to [email protected]<mailto:[email protected]>; • The screenshot should show the period of and up to 31st March 2023. Once the disputed evidence (screenshot) is received, it will be reviewed and verified by a member of NHS NW London Primary Care Team. The evidence will be shared with senior colleagues to authorise the amendments. The PCN achievement will be updated either on CQRS or via an NHS England ready reckoner that’s been provided where CQRS system cannot be updated. PCN Prevalence & Average Prevalence Adjustment The prevalence adjustment for an indicator is equal to the PCN prevalence divided by national average prevalence. Unfortunately we are not able to make changes to the methodology applied to calculate the national average prevalence as this is nationally determined and embedded into the CQRS calculation. However, if you believe your PCN prevalence is incorrect, please review the PCN Network DES IIF reports on CQRS to determine the denominator number used for the calculation and where discrepancies occur, follow the dispute procedure as detailed above. Kind Regards
